Massimo Salvetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Massimo Salvetti has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Enrico Agabiti Rosei
Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
22 shared publications - Maria Lorenza Muiesan
University of Brescia, Brescia, Italy
20 shared publications A. Paini
16 shared publicationsF. Bertacchini
12 shared publicationsE. Agabiti Rosei
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
10 shared publicationsC. Aggiusti
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
8 shared publications
Latest Publications
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e54
[OP.5A.03] RELATIONSHIP BETWEEN LOCAL CAROTID STIFFNESS AND WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e54
[OP.5A.03] RELATIONSHIP BETWEEN LOCAL CAROTID STIFFNESS AND WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e7
[OP.1B.09] RELATIONSHIP BETWEEN CHA2DS2-VASC SCORE AND PRECLINICAL CARDIOVASCULAR ORGAN DAMAGE IN A GENERAL POPULATION IN NORTHERN ITALY
Objective: Background: The CHA2DS2-VASc score is used in patients with atrial fibrillation (AF) for stroke risk stratification. Recent studies have shown that CHA2DS2-VASc is also predictive of cardiovascular (CV) events and mortality, whether or not AF is present. Few data are available on the relationship between CHA2DS2-VASc and preclinical organ damage (OD) in the general population. Design and method: Aim of our study: was to evaluate the relationship between CHA2DS2-VASc and 10 years Framingham risk scores and preclinical cardiac and vascular organ damage in subjects from a general population. Methods: A total of 478 subjects underwent clinical examination with blood pressure measurement (clinic and 24 hours), and laboratory examinations. Left ventricular (LV) and carotid artery structure were assessed by ultrasound and carotid-femoral PWV was measured. OD was defined according to ESH ESC 2013 Guidelines. CHA2DS2-VASc was calculated as recommended by current AF Guidelines. The Framingham risk score for cardiovascular events (FRS CVD), for stroke (FRS stroke) and for coronary heart disease (FRS CHD) were also calculated. Results: Results: mean age was 58 ± 10 (range 43–74 yrs), 44% were males, 69% hypertensives (37% treated). Left ventricular mass index, meanmax IMT and carotid-femoral pulse wave velocity (PWV) were significantly correlated with all the Framingham risk scores as well as with CHA2DS2-VASc (table).The simultaneous inclusion of CHA2DS2-VASc and FRS (for CVD or Stroke or CHD) in linear regression analysis showed that the relationship between CHA2DS2-VASc and OD is independent of FRS. Conclusions: Conclusions: CHA2DS2-VASc score is significantly correlated to preclinical organ damage in patients from a general population.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e7
[OP.1B.09] RELATIONSHIP BETWEEN CHA2DS2-VASC SCORE AND PRECLINICAL CARDIOVASCULAR ORGAN DAMAGE IN A GENERAL POPULATION IN NORTHERN ITALY
Objective: Background: The CHA2DS2-VASc score is used in patients with atrial fibrillation (AF) for stroke risk stratification. Recent studies have shown that CHA2DS2-VASc is also predictive of cardiovascular (CV) events and mortality, whether or not AF is present. Few data are available on the relationship between CHA2DS2-VASc and preclinical organ damage (OD) in the general population. Design and method: Aim of our study: was to evaluate the relationship between CHA2DS2-VASc and 10 years Framingham risk scores and preclinical cardiac and vascular organ damage in subjects from a general population. Methods: A total of 478 subjects underwent clinical examination with blood pressure measurement (clinic and 24 hours), and laboratory examinations. Left ventricular (LV) and carotid artery structure were assessed by ultrasound and carotid-femoral PWV was measured. OD was defined according to ESH ESC 2013 Guidelines. CHA2DS2-VASc was calculated as recommended by current AF Guidelines. The Framingham risk score for cardiovascular events (FRS CVD), for stroke (FRS stroke) and for coronary heart disease (FRS CHD) were also calculated. Results: Results: mean age was 58 ± 10 (range 43–74 yrs), 44% were males, 69% hypertensives (37% treated). Left ventricular mass index, meanmax IMT and carotid-femoral pulse wave velocity (PWV) were significantly correlated with all the Framingham risk scores as well as with CHA2DS2-VASc (table).The simultaneous inclusion of CHA2DS2-VASc and FRS (for CVD or Stroke or CHD) in linear regression analysis showed that the relationship between CHA2DS2-VASc and OD is independent of FRS. Conclusions: Conclusions: CHA2DS2-VASc score is significantly correlated to preclinical organ damage in patients from a general population.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e320
[PP.32.09] EPISTAXIS
Objective Background: Epistaxis and hypertension are frequent diseases in the adult population. A relationship between the increase of the blood pressure (BP) and the prevalence and incidence of epistaxis has been suggested (Kikidis et al, 2013). Design and method: Aim of our study was to analyze blood pressure changes in patients with active or recent onset epistaxis (<12 hours) from admission to the emergency department (ED) to discharge. Patients and methods: 126 consecutive subjects (84 males, age range 15–93 years, mean age 67 ± 17 years) admitted to the ED (April 2014-February 2015) with primary epistaxis, were prospectively evaluated. BP was measured with an automatic device (OMRON MT10-E) in accordance to ESH-ESC guidelines 2013; measurements were performed at admission to the ED and 30 minutes after the ear, nose and throat (ENT) specialist visit (and possible hemostasis). Results Results: a diagnosis of hypertension was present in 68% of subjects; 75% of them were on antihypertensive treatment, 35% of them reported adequate BP control, 17% had diabetes mellitus and 25% dyslipidemia. A statistically significant reduction in BP was observed from admission to the ED and to the end of ENT evaluation (from 142 ± 21/84 ± 13 mmHg to 135 ± 21/81 ± 13 mmHg, p = 0.001), while no significant changes were observed in heart rate (from 76 ± 15 to 72 ± 13 b/min). Conclusions Conclusions: results obtained in this group of patients with primary epistaxis show a prevalence of hypertension similar to that of a general population. An accurate BP measurement shows a significant reduction at the end of the ENT specialist evaluation compared to baseline measurement, in both hypertensive and normotensive subjects.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e320
[PP.32.09] EPISTAXIS
Objective Background: Epistaxis and hypertension are frequent diseases in the adult population. A relationship between the increase of the blood pressure (BP) and the prevalence and incidence of epistaxis has been suggested (Kikidis et al, 2013). Design and method: Aim of our study was to analyze blood pressure changes in patients with active or recent onset epistaxis (<12 hours) from admission to the emergency department (ED) to discharge. Patients and methods: 126 consecutive subjects (84 males, age range 15–93 years, mean age 67 ± 17 years) admitted to the ED (April 2014-February 2015) with primary epistaxis, were prospectively evaluated. BP was measured with an automatic device (OMRON MT10-E) in accordance to ESH-ESC guidelines 2013; measurements were performed at admission to the ED and 30 minutes after the ear, nose and throat (ENT) specialist visit (and possible hemostasis). Results Results: a diagnosis of hypertension was present in 68% of subjects; 75% of them were on antihypertensive treatment, 35% of them reported adequate BP control, 17% had diabetes mellitus and 25% dyslipidemia. A statistically significant reduction in BP was observed from admission to the ED and to the end of ENT evaluation (from 142 ± 21/84 ± 13 mmHg to 135 ± 21/81 ± 13 mmHg, p = 0.001), while no significant changes were observed in heart rate (from 76 ± 15 to 72 ± 13 b/min). Conclusions Conclusions: results obtained in this group of patients with primary epistaxis show a prevalence of hypertension similar to that of a general population. An accurate BP measurement shows a significant reduction at the end of the ENT specialist evaluation compared to baseline measurement, in both hypertensive and normotensive subjects.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.13
Objective: Current hypertension guidelines recommend evaluation of preclinical organ damage (OD) for cardiovascular risk assessment. Prevention and/or regression of OD is one of the main goals of antihypertensive treatment. To assess the differences of vascular OD in a large group of hypertensive patients (HT) and normotensive subjects (N) patients according to antihypertensive treatment and blood pressure (BP) control (BP < 140/90 mmHg). Design and method: A total of 319 subjects (mean age 54 ± 7 yrs), 49 % males, 61 % hypertensives (55 % treated), underwent clinical examination with BP measurement (clinic and 24 hours) and standard laboratory examinations. We compared carotido-femoral pulse wave velocity (PWV), ultrasound carotid intima media thickness (IMT) and wall to lumen ratio of retinal arterioles (WLR) among normotensive subjects (N, n = 125), 87 untreated patients with essential hypertension (UHT), 66 treated patients with controlled essential hypertension (TC_HT) and 41 treated patients with uncontrolled essential hypertension (TUC_HT). OD was defined, according to ESH ESC 2013 Guidelines. Results: In TUC_HT a significant increase in retinal WLR (0.33 + 0.19 and 0.23 + 0.13,p = 0.013) and in carotid mean-max IMT (1.62 + 2.9 vs 0.98 + 0.16, p = 0.014) was observed, as compared to normotensive subjects, while no significant differences between TC_HT and NT were demonstrated. In normotensives cfPWV was significantly lower as compared to TUC_HT (p < 0.05), but not as compared to TC_HT. Conclusions: In hypertensive patients, WLR, IMT and aortic stiffness are slightly, but not significantly, increased when blood pressure is controlled. Vascular damage in treated uncontrolled hypertensives might represent the consequence of increased BP, but might also contribute to poor BP control.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.13
Objective: Current hypertension guidelines recommend evaluation of preclinical organ damage (OD) for cardiovascular risk assessment. Prevention and/or regression of OD is one of the main goals of antihypertensive treatment. To assess the differences of vascular OD in a large group of hypertensive patients (HT) and normotensive subjects (N) patients according to antihypertensive treatment and blood pressure (BP) control (BP < 140/90 mmHg). Design and method: A total of 319 subjects (mean age 54 ± 7 yrs), 49 % males, 61 % hypertensives (55 % treated), underwent clinical examination with BP measurement (clinic and 24 hours) and standard laboratory examinations. We compared carotido-femoral pulse wave velocity (PWV), ultrasound carotid intima media thickness (IMT) and wall to lumen ratio of retinal arterioles (WLR) among normotensive subjects (N, n = 125), 87 untreated patients with essential hypertension (UHT), 66 treated patients with controlled essential hypertension (TC_HT) and 41 treated patients with uncontrolled essential hypertension (TUC_HT). OD was defined, according to ESH ESC 2013 Guidelines. Results: In TUC_HT a significant increase in retinal WLR (0.33 + 0.19 and 0.23 + 0.13,p = 0.013) and in carotid mean-max IMT (1.62 + 2.9 vs 0.98 + 0.16, p = 0.014) was observed, as compared to normotensive subjects, while no significant differences between TC_HT and NT were demonstrated. In normotensives cfPWV was significantly lower as compared to TUC_HT (p < 0.05), but not as compared to TC_HT. Conclusions: In hypertensive patients, WLR, IMT and aortic stiffness are slightly, but not significantly, increased when blood pressure is controlled. Vascular damage in treated uncontrolled hypertensives might represent the consequence of increased BP, but might also contribute to poor BP control.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.12
Objective: It is was suggested that, in resistant hypertension, the presence of particularly pronounced microvascular alterations may contribute to explain the relative lack of response to treatment. Similarly, in diabetic patients, the persistence of an altered microvasciular structure, despite the administration of multiple drug combination treatment, might partly explain the difficulty to reach target blood pressure values, especially for systolic blood pressure.Design and method: For this reason, we investigated a population of 94 treated essential hypertensive patients. Secondary forms of hypertension were excluded according to standard clinical evalutions and biochemical or instrumental assessment, and in all patients a 24-hour blood pressure monitoring was performed in order to exclude a white coat effect. In all patients, we evaluated small resistance arteries morphology by a wire micromyographic approach (Mulvany's technique). A small amount of subcutaneous tissue was obtained by local biopsy or during election surgery and subcutaneous small resistance arteries were dissected and mounted on a myograph; the media to lumen ratio (M/L) was then measured. We subdived our patents according to the presence or not of resistant hypertension (clinic blood pressure values above 140/90 mm Hg despite administration of three antihypertensive agent including a diuretic and 24-hour blood pressure values > 130/80 mm Hg). Sixteen patients had true resistant hypertension, and were compared with the remaining 78 patients with non-resistant hypertension. Results: Results are summarized in the Table (**p < 0.01, ***p < 0.001 vs. non resistant hypertensive patients). The two groups were also different in terms of mean age (57 ± 12 vs. 67 ± 7 years, p = 0.016 and pulse pressure/stroke volume, a rough index of large artery distensibility: 0.63 ± 0.31 vs. 0.90 ± 0.33, p = 0.02). Conclusions: Our data suggest that hypertensive patients with true resistant hypertension have greater microvascular structural alterations compared with non-resistant hypertensive patients. This could explain, at least in part, the resistance to pharmacological treatment and the high cardiovascular risk observed in these patients.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e369
PP.27.12
Objective: It is was suggested that, in resistant hypertension, the presence of particularly pronounced microvascular alterations may contribute to explain the relative lack of response to treatment. Similarly, in diabetic patients, the persistence of an altered microvasciular structure, despite the administration of multiple drug combination treatment, might partly explain the difficulty to reach target blood pressure values, especially for systolic blood pressure.Design and method: For this reason, we investigated a population of 94 treated essential hypertensive patients. Secondary forms of hypertension were excluded according to standard clinical evalutions and biochemical or instrumental assessment, and in all patients a 24-hour blood pressure monitoring was performed in order to exclude a white coat effect. In all patients, we evaluated small resistance arteries morphology by a wire micromyographic approach (Mulvany's technique). A small amount of subcutaneous tissue was obtained by local biopsy or during election surgery and subcutaneous small resistance arteries were dissected and mounted on a myograph; the media to lumen ratio (M/L) was then measured. We subdived our patents according to the presence or not of resistant hypertension (clinic blood pressure values above 140/90 mm Hg despite administration of three antihypertensive agent including a diuretic and 24-hour blood pressure values > 130/80 mm Hg). Sixteen patients had true resistant hypertension, and were compared with the remaining 78 patients with non-resistant hypertension. Results: Results are summarized in the Table (**p < 0.01, ***p < 0.001 vs. non resistant hypertensive patients). The two groups were also different in terms of mean age (57 ± 12 vs. 67 ± 7 years, p = 0.016 and pulse pressure/stroke volume, a rough index of large artery distensibility: 0.63 ± 0.31 vs. 0.90 ± 0.33, p = 0.02). Conclusions: Our data suggest that hypertensive patients with true resistant hypertension have greater microvascular structural alterations compared with non-resistant hypertensive patients. This could explain, at least in part, the resistance to pharmacological treatment and the high cardiovascular risk observed in these patients.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e118-e119
9A.07
Objective: In patients with systemic lupus erythematosus (SLE) a greater prevalence of structural and functional cardiovascular (CV) alterations has been described, possibly explaining the higher incidence of CV events, as compared to subjects matched for age and sex. Aim of this study was to analyze the presence of target organ damage in premenopausal women with SLE and in controls matched not only for demographic characteristics but also for other cardiovascular risk factors. Design and method: 34 patients with SLE clinically stable (SLEDAI Score 2.5 +/- 1.5) (mean age 32 ± 7 years, range 19–44) and 34 controls matched for sex, age, body mass index (BMI), clinic blood pressure (BP) and antihypertensive treatment (if present), underwent: 24 hours BP monitoring, echocardiography with tissue Doppler analysis (TDI) for the evaluation of left ventricular (LV) structure and of systolic and diastolic function, carotid ultrasound for intima-media thickness (IMT) and carotid distensibility measurement, and pulse wave velocity measurement for aortic stiffness (PWV). Results: By definition no difference was observed for age, sex, BMI and clinic BP values and a similar Framingham risk score was observed between SLE and controls (1.3 ± 2.7 vs 1.5 ± 2.3%, p = ns). No significant differences were observed for all echocardiographic parameters except LV longitudinal systolic function (Sm), an early index of LV systolic dysfunction (see Table). Carotid IMT and distensibility, as well as PWV and the prevalence of an abnormal aortic stiffness were both similar in the two groups. At the logistic analysis, PWV was independently associated with LV mass in controls and with the steroid weekly dose in SLE patients.Conclusions: In patients with SLE and low activity index of the disease we did not observe significant vascular alterations as compared to controls with similar cardiovascular risk. The early LV systolic impairment observed in this group of patients needs confirmation in larger cohorts.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e118-e119
9A.07
Objective: In patients with systemic lupus erythematosus (SLE) a greater prevalence of structural and functional cardiovascular (CV) alterations has been described, possibly explaining the higher incidence of CV events, as compared to subjects matched for age and sex. Aim of this study was to analyze the presence of target organ damage in premenopausal women with SLE and in controls matched not only for demographic characteristics but also for other cardiovascular risk factors. Design and method: 34 patients with SLE clinically stable (SLEDAI Score 2.5 +/- 1.5) (mean age 32 ± 7 years, range 19–44) and 34 controls matched for sex, age, body mass index (BMI), clinic blood pressure (BP) and antihypertensive treatment (if present), underwent: 24 hours BP monitoring, echocardiography with tissue Doppler analysis (TDI) for the evaluation of left ventricular (LV) structure and of systolic and diastolic function, carotid ultrasound for intima-media thickness (IMT) and carotid distensibility measurement, and pulse wave velocity measurement for aortic stiffness (PWV). Results: By definition no difference was observed for age, sex, BMI and clinic BP values and a similar Framingham risk score was observed between SLE and controls (1.3 ± 2.7 vs 1.5 ± 2.3%, p = ns). No significant differences were observed for all echocardiographic parameters except LV longitudinal systolic function (Sm), an early index of LV systolic dysfunction (see Table). Carotid IMT and distensibility, as well as PWV and the prevalence of an abnormal aortic stiffness were both similar in the two groups. At the logistic analysis, PWV was independently associated with LV mass in controls and with the steroid weekly dose in SLE patients.Conclusions: In patients with SLE and low activity index of the disease we did not observe significant vascular alterations as compared to controls with similar cardiovascular risk. The early LV systolic impairment observed in this group of patients needs confirmation in larger cohorts.
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e66
5B.01
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e66
5B.01
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e122
9B.08
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e122
9B.08
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e219
PP.10.05
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e219
PP.10.05
- 1 August 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (suppl 1) , P5471
Determinants of change in arterial stiffness in a general population in Northern Italy. The Vobarno study
Background: Carotid-femoral pulse wave velocity (cfPWV) is an independent predictor of cardiovascular events and its measurement is recommended by current hypertension guidelines. Very few data are available on the progression of PWV over time. The aim of the present longitudinal study was to compare the progression of aortic stiffness over a 5-year period in a general population in Northern Italy (Vobarno Study). Methods: 227 subjects, 42% males (age 50±4 years and hypertension in 51% at baseline visit), underwent a baseline (BL) and a follow up (FU) visit, after 5.1±0.4 years. In all subjects laboratory examinations, measurement of clinic and 24 hours blood pressure (BP) and of PWV were performed at BL and at FU. Results: In the overall population cfPWV increased from 8.28±1.27 at BL to 8.51±3.2 m/s at FU (pConclusions: In a general population sample in Northern Italy the main determinants of the increase in arterial stiffness during a 5 years FU were age, cfPWV and mean BP at BL and change in mean BP over time.
- 1 August 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (suppl 1) , P5471
Determinants of change in arterial stiffness in a general population in Northern Italy. The Vobarno study
Background: Carotid-femoral pulse wave velocity (cfPWV) is an independent predictor of cardiovascular events and its measurement is recommended by current hypertension guidelines. Very few data are available on the progression of PWV over time. The aim of the present longitudinal study was to compare the progression of aortic stiffness over a 5-year period in a general population in Northern Italy (Vobarno Study). Methods: 227 subjects, 42% males (age 50±4 years and hypertension in 51% at baseline visit), underwent a baseline (BL) and a follow up (FU) visit, after 5.1±0.4 years. In all subjects laboratory examinations, measurement of clinic and 24 hours blood pressure (BP) and of PWV were performed at BL and at FU. Results: In the overall population cfPWV increased from 8.28±1.27 at BL to 8.51±3.2 m/s at FU (pConclusions: In a general population sample in Northern Italy the main determinants of the increase in arterial stiffness during a 5 years FU were age, cfPWV and mean BP at BL and change in mean BP over time.